company background image
NVST

Envista HoldingsNYSE:NVST Stock Report

Market Cap

US$6.3b

7D

-3.2%

1Y

19.9%

Updated

04 Dec, 2021

Data

Company Financials +
NVST fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance3/6
Financial Health5/6
Dividends0/6

NVST Stock Overview

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally.

Envista Holdings Competitors

Zimmer Biomet Holdings

NYSE:ZBH

US$25.3b

Price History & Performance

Summary of all time highs, changes and price drops for Envista Holdings
Historical stock prices
Current Share PriceUS$38.79
52 Week HighUS$46.52
52 Week LowUS$30.60
Beta1.72
1 Month Change-3.94%
3 Month Change-10.56%
1 Year Change19.91%
3 Year Changen/a
5 Year Changen/a
Change since IPO38.78%

Recent News & Updates

Dec 02
These 4 Measures Indicate That Envista Holdings (NYSE:NVST) Is Using Debt Safely

These 4 Measures Indicate That Envista Holdings (NYSE:NVST) Is Using Debt Safely

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Nov 02
Envista Holdings (NYSE:NVST) Is Experiencing Growth In Returns On Capital

Envista Holdings (NYSE:NVST) Is Experiencing Growth In Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Sep 30
Is Envista Holdings Corporation (NYSE:NVST) Potentially Undervalued?

Is Envista Holdings Corporation (NYSE:NVST) Potentially Undervalued?

Envista Holdings Corporation ( NYSE:NVST ), might not be a large cap stock, but it received a lot of attention from a...

Shareholder Returns

NVSTUS Medical EquipmentUS Market
7D-3.2%-1.8%-2.7%
1Y19.9%8.9%16.6%

Return vs Industry: NVST exceeded the US Medical Equipment industry which returned 8.9% over the past year.

Return vs Market: NVST exceeded the US Market which returned 16.6% over the past year.

Price Volatility

Is NVST's price volatile compared to industry and market?
NVST volatility
NVST Average Weekly Movement3.7%
Medical Equipment Industry Average Movement7.4%
Market Average Movement6.1%
10% most volatile stocks in US Market14.8%
10% least volatile stocks in US Market2.4%

Stable Share Price: NVST is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: NVST's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
201812,400Amir Aghdaeihttps://www.envistaco.com

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company’s Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands.

Envista Holdings Fundamentals Summary

How do Envista Holdings's earnings and revenue compare to its market cap?
NVST fundamental statistics
Market CapUS$6.26b
Earnings (TTM)US$302.90m
Revenue (TTM)US$2.83b

20.7x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NVST income statement (TTM)
RevenueUS$2.83b
Cost of RevenueUS$1.25b
Gross ProfitUS$1.58b
ExpensesUS$1.27b
EarningsUS$302.90m

Last Reported Earnings

Oct 01, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.88
Gross Margin55.80%
Net Profit Margin10.72%
Debt/Equity Ratio33.3%

How did NVST perform over the long term?

See historical performance and comparison

Valuation

Is Envista Holdings undervalued compared to its fair value and its price relative to the market?

13.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: NVST ($38.79) is trading below our estimate of fair value ($44.67)

Significantly Below Fair Value: NVST is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: NVST is good value based on its PE Ratio (20.7x) compared to the US Medical Equipment industry average (44.6x).

PE vs Market: NVST is poor value based on its PE Ratio (20.7x) compared to the US market (16.8x).


Price to Earnings Growth Ratio

PEG Ratio: NVST is poor value based on its PEG Ratio (2.6x)


Price to Book Ratio

PB vs Industry: NVST is good value based on its PB Ratio (1.6x) compared to the US Medical Equipment industry average (3.7x).


Future Growth

How is Envista Holdings forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?

8.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: NVST's forecast earnings growth (8% per year) is above the savings rate (2%).

Earnings vs Market: NVST's earnings (8% per year) are forecast to grow slower than the US market (13.8% per year).

High Growth Earnings: NVST's earnings are forecast to grow, but not significantly.

Revenue vs Market: NVST's revenue (4% per year) is forecast to grow slower than the US market (9.8% per year).

High Growth Revenue: NVST's revenue (4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: NVST's Return on Equity is forecast to be low in 3 years time (8.3%).


Past Performance

How has Envista Holdings performed over the past 5 years?

-16.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NVST has a large one-off loss of $150.4M impacting its October 1 2021 financial results.

Growing Profit Margin: NVST's current net profit margins (10.7%) are higher than last year (0.4%).


Past Earnings Growth Analysis

Earnings Trend: NVST's earnings have declined by 16.8% per year over the past 5 years.

Accelerating Growth: NVST's earnings growth over the past year (3723%) exceeds its 5-year average (-16.8% per year).

Earnings vs Industry: NVST earnings growth over the past year (3723%) exceeded the Medical Equipment industry 51.2%.


Return on Equity

High ROE: NVST's Return on Equity (7.7%) is considered low.


Financial Health

How is Envista Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: NVST's short term assets ($1.8B) exceed its short term liabilities ($1.3B).

Long Term Liabilities: NVST's short term assets ($1.8B) exceed its long term liabilities ($1.3B).


Debt to Equity History and Analysis

Debt Level: NVST's net debt to equity ratio (17.1%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if NVST's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: NVST's debt is well covered by operating cash flow (31.9%).

Interest Coverage: NVST's interest payments on its debt are well covered by EBIT (7.3x coverage).


Balance Sheet


Dividend

What is Envista Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NVST's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NVST's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NVST's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NVST's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NVST's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.3yrs

Average management tenure


CEO

Amir Aghdaei (62 yo)

2.25yrs

Tenure

US$7,370,894

Compensation

Mr. Amir Aghdaei has been President, Chief Executive Officer at Envista Holdings Corporation since September 20, 2019 and its Director since May 2019. Mr. Amir Aghdaei served as President and Group Execut...


CEO Compensation Analysis

Compensation vs Market: Amir's total compensation ($USD7.37M) is about average for companies of similar size in the US market ($USD6.35M).

Compensation vs Earnings: Amir's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: NVST's management team is considered experienced (2.3 years average tenure).


Board Members

Experienced Board: NVST's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Envista Holdings Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Envista Holdings Corporation
  • Ticker: NVST
  • Exchange: NYSE
  • Founded: 2018
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$6.259b
  • Shares outstanding: 161.37m
  • Website: https://www.envistaco.com

Number of Employees


Location

  • Envista Holdings Corporation
  • Building E
  • 200 South Kraemer Boulevard
  • Brea
  • California
  • 92821-6208
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/12/04 00:18
End of Day Share Price2021/12/03 00:00
Earnings2021/10/01
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.